Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
24.47
+4.03 (19.72%)
At close: Oct 8, 2025, 4:00 PM EDT
24.74
+0.27 (1.10%)
After-hours: Oct 8, 2025, 4:16 PM EDT

Intellia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
2,6271,1882,7312,9748,7993,514
Upgrade
Market Cap Growth
18.18%-56.51%-8.18%-66.20%150.41%390.02%
Upgrade
Enterprise Value
2,2943441,8562,2237,7273,128
Upgrade
Last Close Price
20.4411.6630.4934.89118.2454.40
Upgrade
PS Ratio
39.6520.5275.2757.06266.2260.59
Upgrade
PB Ratio
3.011.362.602.418.466.67
Upgrade
P/TBV Ratio
3.951.362.602.418.466.67
Upgrade
EV/Sales Ratio
43.405.9551.1742.65233.7653.94
Upgrade
Debt / Equity Ratio
0.140.240.110.110.070.08
Upgrade
Asset Turnover
0.050.050.030.040.030.12
Upgrade
Quick Ratio
4.935.508.239.455.979.33
Upgrade
Current Ratio
5.195.778.669.626.119.60
Upgrade
Return on Equity (ROE)
-56.95%-54.01%-42.10%-41.67%-34.19%-33.69%
Upgrade
Return on Assets (ROA)
-30.62%-26.80%-22.83%-20.35%-16.99%-16.89%
Upgrade
Return on Capital (ROIC)
-33.77%-29.71%-25.44%-23.09%-19.92%-19.98%
Upgrade
Earnings Yield
-17.02%-43.70%-17.62%-15.95%-3.04%-3.82%
Upgrade
FCF Yield
-14.95%-29.87%-14.95%-11.66%-2.70%-1.52%
Upgrade
Buyback Yield / Dilution
-10.38%-11.35%-15.33%-8.57%-26.63%-18.50%
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q